Kim et al. [38] constructed a nanocomplex based on the cationic liposome decorated with a monoclonal antibody (TfRscFv) to deliver anti-MALAT1 siRNA for RNAi therapy of GBM. Here, MALAT1 is linked to glioblastoma.